Already inside the gate: the company is specified into someone else's next wave, and the wave has not yet shipped
The model's full reasoning — Q1 2017 call → NO我们根据提供的电话会议记录来判断。问题核心是:公司是否已经在一个外部组织的未来产品/计划中被选定、指定、合格化、设计进去或锁定位置,且该外部组织的浪潮尚未到来,而公司已准备好迎接。 分析记录内容: - 关于SPINRAZA:与Biogen合作,SPINZA已上市销售,第一季度销售额超过4700万美元,这是已经发生的销售,不是未来浪潮。但记录提到“SPINRAZA launch gaining momentum”,且Biogen正在扩大市场,但SPINRAZA已经上市,所以不是“尚未发货”的浪潮。 - 关于volanesorsen:Akcea(Ionis子公司)计划在第三季度提交监管申请,准备2018年上市。这是未来事件,但公司尚未被选定为某个外部组织的未来产品的一部分?实际上,volanesorsen是Ionis自己的药物,不是嵌入到其他公司的产品中。 - 关于IONIS-TTRRx:计划本季度报告III期数据,然后与GSK合作提交申请。这也是自己的药物。 - 关于与Novartis的合作:Novartis支付了1.75亿美元,用于开发AKCEA-APO(a)-LRx和AKCEA-APOCIII-LRx。这些药物是Akcea的,Novartis将负责开发和商业化。但这是合作,不是公司被嵌入到Novartis的未来产品中?实际上,是Novartis选择这些药物,但公司是开发方,不是被选定的供应商。而且这些药物还在早期阶段。 - 关于与Bayer的合作:Bayer支付7500万美元推进IONIS-FXIRx和IONIS-FXI-LRx。同样,这是合作开发,不是公司被嵌入到Bayer的未来产品中。 - 关于与AstraZeneca的合作:提到“cardiorenal collaboration”,但未具体说明。 关键点:公司是否已经“被选定”为某个外部组织的未来产品的一部分?例如,像供应商被设计到客户的产品中。但这里,Ionis是药物开发者,合作伙伴是共同开发或商业化。没有明确描述公司被嵌入到另一个组织的未来产品中,而是公司自己的药物被合作伙伴商业化。 此外,关于SPINRAZA,虽然销售已开始,但记录提到“launch gaining momentum”,但销售已经发生,不是未来浪潮。关于volanesorsen,尚未上市,但这是公司自己的药物,不是嵌入到其他公司的产品中。 因此,不符合“公司已经占据另一个组织未来产品中的位置”的条件。更像是公司自己开发产品,然后与合作伙伴合作。 所以答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| CLGN | CollPlant Biotechnologies Ltd. | Q4 2023 | 2024-04-04 | F |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| AIRG | Airgain, Inc. | Q3 2023 | 2023-11-09 | F |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| THRM | Gentherm Incorporated | Q2 2016 | 2016-07-28 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
CUBI · Q3 2018 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will come automatically when ...NO The transcript describes a white-label partnership with T-Mobile where BankMobile provides services under T-Mobile's brand, with deposits expected to start in the next year after the launch. However, this does not meet the criteria for a secured position inside T-Mobile's next product or program. The language focuses on a partnership relationship that is still being launched, rather than a design win or qualification already embedded in T-Mobile's future offering. Management refers to it as an "expected white label partnership" and "working on" the launch, indicating it is not yet locked in as part of T-Mobile's committed plan.
EMKR · Q4 2023 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will come automatically when ...NO The transcript describes an agreement with Kratos for Inertial Navigation Systems to be included in the XQ58 Valkyrie drone, with the Air Force planning to acquire at least 1,000 units. However, this is framed as an announcement of a new agreement rather than a secured, locked-in position already designed 100% into the platform with volume guaranteed.
NC · Q1 2024 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will arrive automatically whe...